| 5-FU | 5-Fluorouracil |
| aa | amino acid |
| ASPP | apoptosis-stimulating of p53 protein |
| CSC | cancer stem cell |
| CIMP | CpG island methylator phenotype |
| CIN | chromosomal instability |
| CMS | Consensus Molecular Subtype |
| COAD | colorectal adenocarcinoma |
| CRC | colorectal cancer |
| CTD | C-terminal domain |
| DBD | DNA-binding domain |
| DN | dominant-negative |
| DNE | dominant-negative effect |
| GOF | gain-of-function |
| HLA | human leukocyte antigen |
| HZF | hematopoietic zinc finger |
| IARC | International Agency for Research on Cancer |
| ICI | immune checkpoint inhibitor |
| IHC | immunohistochemistry |
| lncRNA | long non-coding RNA |
| LOF | loss-of-function |
| MHC I | major histocompatibility complex class I |
| miRNA | microRNA |
| MM | multiple myeloma |
| MSI | microsatellite instability |
| ncRNA | non-coding RNA |
| OD | oligomerization domain |
| PKC | protein kinase C |
| PLK1 | polo-like kinase 1 |
| PRD | proline-rich domain |
| PTM | post-translational modification |
| RE | response element |
| ROS | reactive oxygen species |
| TAD | Transactivation domain |
| TCR | T-cell receptor |
| TF | transcription factor |